Scientific Publications

Original Articles

  1. Billington CJ, Sarr MG, Brancatisano R, Toouli J, Nguyen N, Blackstone R,  Maher JW, Shikora S,  Reeds DN, Wolfe BW, Fujioka K, Swain JM, Morton.JM, Ikramuddin S,  Schweitzer M, Chand B, Rosenthal R, Brancatisano A, Kow L, Eagon JC, Takata M,  and O’Rourke RW. The EMPOWER study: randomised, prospective, double blind, multicentre trial of vagal blockade to induce weight loss in morbid obesity. Obesity Surgery, 2012
  2. Shikora S, Toouli J, Herrera MF, MD, Kulseng B, Zulewski H,  Brancatisano R, Kow L,  Pantoja JP, Johnsen G, Brancatisano A, Tweden KS, Knudson MB, Billington CJ. Vagal block improves glycaemic control and elevated blood pressure in obese subjects with type 2 diabetes. Surgery for Obesity and Related Disease, 2012
  3. Keogh JB, Brancatisano A, Taylor S, McDonald F, Brancatisano R, Hamdorf, J, Chisholm J, Ryan B, and Toouli, J.  Clinical evaluation of the REALIZE™ Adjustable Gastric Band-C (SAGB-VC) in an Australian population. Canadian Journal of Surgery, 2011
  4. Herrera MF, R Brancatisano, B Kulseng, J Toouli, , A Brancatisano,  L Kow, , G   Johnsen, JP Pantoja,, MB Knudson, , KS Tweden, , RW Wilson, , CJ Billington, Vagal blocking improves glycemic control and blood pressure in obese subjects with type 2 diabetes mellitus and hypertension. Surgery for Obesity and Related Diseases, 2010
  5. Brancatisano A, Wahlroos S, Brancatisano R. Improvement in co morbid illness following placement of the Swedish Adjustable Gastric Band. Surg Obes Relat Dis. 2008 May-Jun;4(3 Suppl):S39-46
  6. Brancatisano A, Wahlroos S, Matthews S, Brancatisano R. Gastric banding for the treatment of type 2 diabetes mellitus in the morbidly obese. Surg Obes Relat Dis. 2008 May-Jun;4(3):423-9
  7. Sara Wahlroos, Madeleine L Phillips, Mark C Lewis, Lilian Kow, J Toouli, John P Slavotinek, Robin Valentine & Campbell H Thompson; Rapid significant weight loss and regional lipid deposition: implications for insulin sensitivity. Obesity Research & Clinical Practice. Vol 1, Issue 1, January 2007: 7-16

Abstracts

  1. Brancatisano A. What should be the primary outcome measure of a bariatric procedure?; improvement in health outcomes. OSSANZ Scientific Conference, 2012
  2. Brancatisano A, Brancatisano R. Self Modulating Gastric Band Accessory - First-in-Human Clinical Trial Design and Initial Safety Results. OSSANZ Scientific Conference, 2012
  3. Brancatisano A, Fishler M, Phillips M, Meyer S, Brancatisano R, Lau L. Self Modulating Gastric Band Accessory - Results from In Vitro Studies. OSSANZ Scientific Conference, 2012
  4. Brancatisano, R Brancatisano A. Laparoscopic Gastric Plication combined with Adjustable Gastric Banding:  Surgical Procedure and Preliminary Findings. OSSANZ Scientific Conference, 2012
  5. Toouli T,Herrera M, Kulseng B, Brancatisano R, Pantoja J B, Johnsen G, Brancatisano A, Tweden K, Kow L.  Vagal Blocking: Treatment of Obesity Related Type 2 Diabetes and Blood Pressure - 18 Month Results. OSSANZ Scientific Conference, 2012
  6. Fried M, Toouli J, Brancatisano A, Gutierrez M, and Ghosh S K. A 20ml water bolus is an acceptable bolus medium and volume for the measurement of intra-band pressure in the Swedish Adjustable Gastric Band (SAGB). Presented at the International Federation for Surgical Obesity, Hamburg, Germany, September 2011
  7. Herrera MF, Toouli J, Kulseng B, Brancatisano R, Zulewski H Pantoja JP, Kow L Johnsen G, Brancatisano A, Frey, DM, Tweden KS, Billington, CJ.  Treatment of obesity-related co-morbidities with VBLOC Therapy.  Presented at the International Federation for Surgical Obesity, Hamburg, Germany, September 2011
  8. Brancatisano R, Toouli J, Nguyen N, Blackstone R, Maher J, Shikora S, Reeds D, Wolfe B, Fujioka K, Swain J, Morton J, Ikramuddin S, Schweitzer M, Chand B, Rosenthal R, Brancatisano A, Kow L, Eagon C, Takata M, O’Rourke R, Sarr M. EMPOWER:  A 12 month randomized, prospective clinical trial:  safety and effectiveness of VBLOC therapy.  OSSANZ Scientific Conference 2010
  9. Kow L, Herrera MF, Kulseng B, Brancatisano R, Zulewski H, Brancatisano A, Pantoja JP, Johnsen G, Frey DM, Tweden KS, J Toouli.  Vagal blocking improves obesity related co morbidities in obese patients with type 2 diabetes.  OSSANZ Scientific Conference 2010
  10. Herrera MF, Pantoja, JP, Brancatisano R, Brancatisano A,  Zulewski H, Frey, DM, Kulseng B, Johnsen G, Toouli J, Kow L, Tweden KS, Vollmer, MC, Wilson, RR, Billington, CJ.  Vagal Blocking Improves Glycemic Control and Blood Pressure in Subjects with Type 2 Diabetes and Hypertension.  Surgery for Obesity and Related Diseases 2010:6:PL-316 (presented at Annual Meeting, American Society for Metabolic and Bariatric Surgery, Las Vegas, NV, 21-26 June, 2010)
  11. Brancatisano A, Wahlroos S, R Brancatisano.  Comparable excess weight loss (EWL) using the new generation Swedish adjustable gastric band – SAGB VC. OSSANZ 2009
  12. Brancatisano, A, Tweden, KS, Vollmer MC, Wilson RR, Yurik T, Brancatisano R, Kow J, and Toouli J.  Intermittent vagal block with an implantable medical device improves blood pressure in obese subjects.  OSSANZ 2009
  13. Brancatisano R, Tweden, KS, Vollmer MC, Wilson RR, Yurik T, Brancatisano A, Kow J, and Toouli J.  Implantation technique of a novel vagal blockade medical device for the treatment of obesity.  OSSANZ 2009
  14. Kow J, Toouli J, Tweden, KS, Vollmer MC, Wilson RR, Yurik T, Brancatisano R, and Brancatisano, A.  Intermittent vagal blocking with an implantable device: Selection of electrical algorithms to treat obesity.  OSSANZ 2009
  15. Brancatisano, A, Wahlroos, S, Brancatisano R. Quality of life before and after gastric banding in a multidisciplinary institution. Surgery for Obesity and Related Diseases. 3 (3), 321, 2007
  16. Brancatisano, A, Wahlroos S, Brancatisano R. Weight loss outcomes using the Swedish adjustable gastric band in the morbidly obese: Single surgeon experience in 774 patients. Surgery Obesity Related Diseases, 3 (3), 317, 2007
  17. Brancatisano, A, Wahlroos S, Brancatisano R. Gastric banding for the treatment of type 2 diabetes mellitus in the morbidly obese.Surgery Obesity Related Diseases. 3 (3), 290-291, 2007
  18. Brancatisano A, Wahlroos S, Brancatisano R. Gastric Banding for the Treatment of Type 2 Diabetes Mellitus in the Morbidly Obese. Australian Diabetes Society Scientific Meeting, 23rd-25th August, A300, 124, 2006
  19. Brancatisano R, Wahlroos, S, Brancatisano A. Laparoscopic Gastric Banding in the Morbidly Obese: Single Surgeon Experience of 520 patients. Obesity Surgery, A69, 1009, 2006
  20. Brancatisano A, Wahlroos, R Brancatisano. Improvements in Quality of Life in Morbidly Obese Patients Following Gastric Banding in a Multidisciplinary Institution. Obesity Surgery A93, 1014, 2006
  21. Brancatisano A, Wahlroos, R Brancatisano. Health Outcomes in Obese Patients after Weight Loss Surgery using the Swedish Adjustable Gastric Band. Obesity Surgery, A146, 1027, 2006
  22. Brancatisano A, Moulos M, Theodorou T, Turton A, Young G, Christian J, and Brancatisano R Weight Control Surgery using the Swedish Adjustable Gastric Band (SAGB): the Sydney experience. Obesity Surgery, A215, volume 15, 986, 2005
  23. Brancatisano R, Moulos M, Theodorou T, Turton A, Young G, Christian J, and Brancatisano A Concurrent laparascopic gastric banding and hiatus hernia repair in morbidly obese patients. Obesity Surgery, A215, volume 15, 985, 2005
  24. Brancatisano R Moulos M, Theodorou T, Turton A, Young G, Christian J, and Brancatisano A Multi disciplinary follow up improves results following adjustable gastric band surgery for the morbidly obese. 20th Annual Scientific Meeting of the Obesity Surgery Society of Australia and New Zealand. 2005